02:53 , Dec 8, 2017 |  BC Week In Review  |  Company News

Bristol-Myers, Allied JV licenses immunoproteosome inhibitors from Cornell

Allied-Bristol Life Sciences formed ABLS IV, a new subsidiary which exclusively licensed immunoproteosome inhibitors from Weill Cornell Medical College and Cornell University to treat autoimmune and inflammatory diseases. ABLS IV will conduct and fund initial...
20:56 , Aug 17, 2017 |  BC Innovations  |  Finance

Built to purpose

With almost 40 start-ups engaging in build-to-buy deals since 2013 and an average 2-4 years for up or down decisions, the next year could see a spate of acquisitions -- or options declined -- that...
07:00 , Sep 5, 2016 |  BC Week In Review  |  Financial News

ABLS II completes venture financing

Allied-Bristol Life Sciences II LLC , Boston, Mass.   Business: Autoimmune, Inflammation   Date completed: 2016-08-22   Type: Venture financing   Raised: $15 million   Investors: Allied Minds; Bristol-Myers Squibb Co.  ...
07:00 , Aug 22, 2016 |  BC Extra  |  Financial News

ABLS spinout raises $15M in series A round

Allied Minds plc (LSE:ALM) said fibrosis and autoimmune start-up ABLS II LLC raised $15 million in a series A round. ABLS II is among three companies spun out from joint venture Allied-Bristol Life Sciences LLC,...
07:00 , May 30, 2016 |  BC Week In Review  |  Company News

Bristol-Myers, Allied Minds deal

Allied-Bristol Life Sciences, a jointly owned company formed in 2014 by Bristol-Myers Squibb and Allied Minds, said its ABLS II LLC subsidiary completed its drug candidate feasibility program. The subsidiary will receive $15 million to...
01:14 , Apr 27, 2016 |  BC Extra  |  Financial News

Allied Minds creates funding vehicle for BMS JV

The newly formed ABLS Capital subsidiary of Allied Minds plc (LSE:ALM) has secured commitments of up to $80 million to fund programs in Allied Minds' joint venture with Bristol-Myers Squibb Co. (NYSE:BMY). The funds will...
07:00 , Oct 12, 2015 |  BC Week In Review  |  Financial News

Precision Biopsy completes venture financing

Precision Biopsy LLC , Aurora, Colo.   Business: Diagnostic   Date completed: 2015-10-05   Type: Venture financing   Raised: $33.6 million   Investors: Woodford Investment Management; Allied Minds  ...
07:00 , Oct 5, 2015 |  BC Week In Review  |  Company News

Yale University, Allied Minds, Bristol-Myers deal

Yale granted Allied-Bristol Life Sciences LLC, a JV between Allied Minds and Bristol-Myers Squibb, a worldwide license to the university’s platform technology and associated lead molecules. The compounds are antibody-recruiting molecules that use the patient’s...
07:00 , Aug 3, 2015 |  BC Week In Review  |  Company News

Bristol-Myers, Allied Minds, Harvard deal

The university granted Allied-Bristol Life Sciences LLC, a JV between Allied Minds and Bristol-Myers Squibb, rights to IP that covers lead molecules targeting the mechanism of halofuginone. The natural product, found in the root of...
00:46 , May 27, 2015 |  BC Extra  |  Financial News

PureTech plans $160M LSE listing

PureTech Ventures (Boston, Mass.) intends to raise about $160 million in an IPO on the London Stock Exchange in June. The firm plans to invest the proceeds to develop its existing portfolio companies' pipeline candidates...